高级检索
当前位置: 首页 > 详情页

Diagnostic performance of circulating MicroRNAs in acute ischemic stroke: A protocol for systematic review and meta-analysis.

文献详情

资源类型:
Pubmed体系:
机构: [a]Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang, Sir Run Run Shaw Hospital, Medical School of Zhejiang University, Hangzhou, Zhejiang [b]TheInstitute of Cardiovascular Research, SouthWest Medical University, Luzhou, Sichuan [c]Department of Nursing, Sichuan Vocational College of Health and Rehabilitation,Zigong [d]School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu [e]School of Nursing, SouthWest Medical University, Luzhou,Sichuan, P.R. China
出处:
ISSN:

关键词: biomarker diagnosis ischemic stroke meta-analysis microRNA

摘要:
Increasing evidences showed differential expression of circulating microRNAs (miRNAs) in patients with acute ischemic stroke (AIS), indicating that miRNAs might serve as promising biomakers in the diagnosis of AIS. However, their accuracy has not been systematically evaluated, so it is necessary to conducted a meta-analysis to evaluate the diagnostic value of miRNAs in AIS patients.PubMed, EMBASE, Cochrane Library, Web of Science, Medline, China National Knowledge Infrastructure (CNKI) will be searched for the relevant studies that explored the potential diagnostic values of miRNAs in AIS patients from inception to August 2020. Data will be extracted by two researchers independently; risk of bias of the meta-analysis will be evaluated by the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2). Data will be synthesised and heterogeneity will be evaluated. All of the above statistical analysis will be performed using Stata V.15.0 and Meta-disc V.1.4. This study will assess the pooled diagnostic performance of circulating miRNAs in AIS. This study will clarify confusions about the specificity and sensitivity of circulating miRNAs in diagnosing AIS, which could further guide the promotion and application of them.Open Science Framework (OSF) registration number: 2020, August 19. https://osf.io/6tjf3.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
第一作者:
第一作者机构: [a]Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang, Sir Run Run Shaw Hospital, Medical School of Zhejiang University, Hangzhou, Zhejiang [b]TheInstitute of Cardiovascular Research, SouthWest Medical University, Luzhou, Sichuan
共同第一作者:
通讯作者:
通讯机构: [a]Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang, Sir Run Run Shaw Hospital, Medical School of Zhejiang University, Hangzhou, Zhejiang [e]School of Nursing, SouthWest Medical University, Luzhou,Sichuan, P.R. China [*1]SouthWest Medical University, No.1 Xianglin Road, Louzhou, 646000, Sichuan Province [*2]Hongchuan Jin, Medical School of Zhejiang University, No.866 Yuhangtang Road, Hangzhou, 310000, Zhejiang Province, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号